Given that SRF is capable of promoting human glioma cell migration52 and Lpd overexpression has been detected in glioma samples from patients,53 investigation into whether Lpd or SRF levels are associated with disease progression and patient outcome is warranted. This evidence concerns the gene SRF and central nervous system cancer.